CVS HEALTH CORP (CVS) Stock Institutional Trading Activity


CVS HEALTH CORP (CVS) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Hancock Classic Value, Ariel Appreciation Fund, Olstein Capital Management, Cullen Value Fund, and Tweedy, Browne Co All Funds (US). Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2023Hillman Value FundBuy1,354113,662$8,974,752
Q4 2023Sequoia Financial AdvisorsBuy56,232290,232$22,916,706
Q4 2023Matrix Advisors Value FundSell-15,160291,154$22,989,520
Q4 2023Hancock Classic ValueSell-411,330824,250$65,082,780
Q4 2023Turtle Creek Asset ManagementSell-124,9501,701,600$134,358,336
Q4 2023Cullen Value FundBuy42,06242,062$3,321,221
Q3 2023Dodge & Cox Stock FundBuy10,698,56026,722,982$1,865,798,603
Q3 2023Olstein Capital ManagementBuy17,000155,000$10,822
Q3 2023Matrix Private Capital GroupSell-613,615$950,599
Q3 2023Bill & Melinda Gates Foundation TrustBuy32,50032,500$2,269,150
Q3 2023Hillman Value FundBuy16,613112,308$7,841,345
Q3 2023Sequoia Financial AdvisorsBuy28,537234,000$16,337,861
Q3 2023Matrix Advisors Value FundBuy1,613306,314$21,386,843
Q3 2023Turtle Creek Asset ManagementBuy1,776,2001,826,550$127,529,721
Q2 2023Dodge & Cox Stock FundBuy3,417,57316,024,422$1,107,768,293
Q2 2023Olstein Capital ManagementBuy20,000138,000$9,540
Q2 2023Renaissance Technologies LLCSell-3,644,1001,425,853$98,569
Q2 2023Matrix Private Capital GroupSell-10613,621$941,620
Q2 2023Turtle Creek Asset ManagementBuy18,40050,350$3,480,696
Q2 2023Hillman Value FundSell-65295,695$6,615,396
Q2 2023Scion Asset ManagementSell-100,000100,000$6,913,000
Q2 2023Muhlenkamp & CoBuy572110,695$7,652,345
Q2 2023Sequoia Financial AdvisorsBuy56,289205,463$14,203,686
Q2 2023Matrix Advisors Value FundBuy6,229304,701$21,063,980
Q1 2023Dodge & Cox Stock FundBuy5,96212,606,849$936,814,949
Q1 2023Olstein Capital ManagementBuy40,000118,000$8,769
Q1 2023Renaissance Technologies LLCBuy2,508,5005,069,953$376,748
Q1 2023Matrix Private Capital GroupSell-59613,727$1,020,053
Q1 2023Turtle Creek Asset ManagementBuy26,50031,950$2,374,205
Q1 2023Hillman Value FundBuy71296,347$7,159,545

Frequently asked questions about CVS activity

  • Which institutional owners are buying CVS?

    Institutional owners buying CVS include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in CVS activity?

    "Buy" means an investor increased their reported position in CVS compared to the prior reporting period. This reflects growing exposure to CVS HEALTH CORP (CVS) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in CVS increasing?

    Institutional interest in CVS can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.